bf/NASDAQ:BMRN_icon.png

COM:BIOMARIN

BioMarin

  • Stock

USD

Last Close

63.45

22/11 21:00

Market Cap

15.63B

Beta: -

Volume Today

1.20M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
145.65M
-
181.03M
24.29%
235.57M
30.13%
313.40M
33.04%
415.45M
32.56%
503.32M
21.15%
605.57M
20.31%
689.41M
13.84%
737.61M
6.99%
835.38M
13.25%
average payables
121.19M
-
165.52M
36.58%
314.13M
89.78%
381.51M
21.45%
386.21M
1.23%
419.61M
8.65%
503.96M
20.10%
381.02M
24.39%
192.22M
49.55%
212.12M
10.36%
average receivables
113.44M
-
131.15M
15.61%
154.72M
17.97%
190.12M
22.88%
238.32M
25.35%
302.00M
26.72%
360.02M
19.21%
412.88M
14.68%
410.88M
0.49%
417.36M
1.58%
book value per share
9.73
-
10.44
7.24%
15.00
43.71%
16.67
11.08%
16.10
3.38%
16.76
4.10%
17.44
4.04%
22.71
30.22%
23.36
2.85%
24.85
6.38%
capex per share
-0.47
-
-0.81
71.76%
-1.42
75.20%
-0.89
37.16%
-1.14
27.76%
-0.82
28.49%
-0.91
11.74%
-0.76
16.66%
-0.65
14.27%
-0.71
8.89%
-0.50
28.92%
capex to depreciation
-1.38
-
-2.09
51.99%
-4.82
130.37%
-1.53
68.26%
-2.27
48.09%
-1.51
33.33%
-1.55
2.66%
-1.31
15.74%
-1.10
15.60%
-1.29
16.90%
-1.02
21.23%
capex to operating cash flow
1.09
-
1.62
47.97%
1.03
36.45%
0.65
36.58%
22.75
3,393.21%
-7.16
131.46%
-3.39
52.69%
-1.61
52.42%
-0.39
75.70%
-0.75
91.01%
-0.61
18.81%
capex to revenue
-0.12
-
-0.16
33.26%
-0.26
61.68%
-0.13
48.07%
-0.15
14.15%
-0.10
36.05%
-0.10
1.12%
-0.07
22.92%
-0.06
12.64%
-0.06
2.82%
-0.04
36.31%
cash per share
5.70
-
6.46
13.38%
3.70
42.66%
4.76
28.47%
8.00
68.22%
6.12
23.48%
4.21
31.25%
5.89
39.95%
5.54
5.90%
6.97
25.73%
days of inventory on hand
619.90
-
561.02
9.50%
652.36
16.28%
618.36
5.21%
718.23
16.15%
614.62
14.43%
690.75
12.39%
486.33
29.59%
602.50
23.89%
674.72
11.99%
days payables outstanding
363.32
-
663.09
82.51%
942.49
42.14%
645.14
31.55%
606.74
5.95%
506.28
16.56%
579.41
14.44%
133.27
77.00%
149.72
12.34%
174.50
16.55%
days sales outstanding
78.41
-
70.21
10.45%
67.66
3.64%
70.36
3.98%
72.62
3.22%
83.87
15.48%
80.84
3.61%
87.96
8.81%
73.82
16.08%
80.33
8.82%
debt to assets
0.29
-
0.26
9.35%
0.18
32.78%
0.17
4.38%
0.25
49.29%
0.19
26.00%
0.18
3.59%
0.19
2.78%
0.18
2.35%
0.17
5.50%
debt to equity
0.49
-
0.43
11.91%
0.28
35.94%
0.25
10.46%
0.42
69.30%
0.28
33.09%
0.27
2.92%
0.26
2.55%
0.26
3.62%
0.24
6.89%
dividend yield
earnings yield
-0.02
-
-0.01
44.35%
-0.01
1.20%
-0.05
347.24%
-0.01
83.58%
-0.01
31.94%
-0.00
69.24%
0.05
3,539.50%
-0.00
107.32%
0.01
286.14%
0.01
22.91%
enterprise value
9.78B
-
13.01B
33.08%
17.03B
30.87%
14.03B
17.64%
16.13B
15.01%
15.41B
4.44%
15.55B
0.88%
16.28B
4.71%
16.65B
2.25%
19.53B
17.33%
enterprise value over ebitda
-82.31
-
-94.46
14.76%
-59.28
37.24%
-72.88
22.95%
-224.98
208.68%
-153.75
31.66%
-699.03
354.66%
-2.78K
298.13%
346.62
112.45%
122.44
64.67%
ev to operating cash flow
-163.96
-
-176.95
7.92%
-76.82
56.59%
-61.56
19.86%
-1.84K
2,892.26%
762.73
141.41%
322.17
57.76%
190.72
40.80%
54.66
71.34%
111.04
103.13%
ev to sales
17.83
-
17.33
2.81%
19.14
10.45%
12.56
34.38%
12.28
2.22%
10.34
15.82%
9.12
11.72%
8.75
4.09%
9.02
3.03%
9.32
3.35%
free cash flow per share
-0.91
-
-1.31
45.14%
-2.81
113.62%
-2.27
19.28%
-1.19
47.39%
-0.70
41.07%
-0.64
8.47%
-0.29
55.15%
1.01
451.34%
0.24
76.37%
0.33
36.38%
free cash flow yield
-0.01
-
-0.01
12.95%
-0.03
84.33%
-0.03
2.08%
-0.01
51.13%
-0.01
38.29%
-0.01
7.82%
-0.00
56.75%
0.01
448.71%
0.00
79.83%
0.00
46.38%
graham net net
0.34
-
1.30
288.42%
-2.98
328.42%
-0.78
73.95%
0.03
104.01%
0.83
2,582.83%
-1.06
227.81%
0.05
104.63%
-0.28
658.80%
1.69
713.15%
graham number
16.75
-
14.66
12.43%
19.04
29.82%
37.73
98.21%
15.59
58.68%
12.82
17.75%
7.23
43.63%
49.27
581.56%
13.57
72.46%
20.67
52.30%
income quality
0.34
-
0.55
62.33%
1.29
135.08%
0.36
71.98%
0.07
79.30%
-0.26
449.81%
-2.02
673.23%
0.10
104.91%
-4.75
4,882.78%
1.24
126.15%
0.95
23.55%
intangibles to total assets
0.10
-
0.08
12.42%
0.24
179.06%
0.19
21.01%
0.15
17.35%
0.16
0.89%
0.14
10.43%
0.10
24.73%
0.10
7.13%
0.08
13.90%
0
100%
interest coverage
-14.93
-
-2.54
83.02%
-2.89
14.18%
-20.34
602.70%
-0.34
98.31%
-2.83
721.88%
-5.35
89.03%
-3.28
38.58%
-3.91
19.14%
3.60
192.09%
-9.12
353.10%
interest debt per share
4.83
-
4.75
1.83%
4.38
7.77%
4.35
0.53%
6.98
60.26%
4.94
29.26%
4.87
1.39%
6.17
26.82%
6.04
2.12%
5.99
0.90%
inventory turnover
0.59
-
0.65
10.50%
0.56
14.00%
0.59
5.50%
0.51
13.90%
0.59
16.86%
0.53
11.02%
0.75
42.03%
0.61
19.28%
0.54
10.70%
invested capital
0.49
-
0.43
11.91%
0.28
35.94%
0.25
10.46%
0.42
69.30%
0.28
33.09%
0.27
2.92%
0.26
2.55%
0.26
3.62%
0.24
6.89%
market cap
9.69B
-
13.23B
36.52%
16.76B
26.71%
13.75B
17.98%
15.55B
13.12%
15.08B
3.07%
15.14B
0.40%
15.85B
4.74%
16.15B
1.89%
19.17B
18.68%
18.47T
96,251.21%
net current asset value
229.24M
-
463.07M
102.00%
-238.88M
151.59%
164.38M
168.81%
382.68M
132.81%
597.03M
56.01%
374.49M
37.28%
600.20M
60.27%
541.80M
9.73%
979.54M
80.79%
net debt to ebitda
-0.73
-
1.58
316.12%
-0.92
158.48%
-1.43
54.73%
-8.04
462.79%
-3.36
58.26%
-18.46
450.16%
-72.82
294.40%
10.24
114.06%
2.25
78.05%
net income per share
-1.28
-
-0.92
28.49%
-1.07
17.28%
-3.80
253.66%
-0.67
82.33%
-0.44
35.01%
-0.13
69.45%
4.75
3,667.23%
-0.35
107.38%
0.76
318.03%
0.87
14.51%
operating cash flow per share
-0.43
-
-0.50
16.08%
-1.39
175.69%
-1.37
0.92%
-0.05
96.34%
0.11
327.33%
0.27
136.19%
0.47
75.15%
1.67
252.75%
0.95
42.99%
0.83
12.45%
payables turnover
1.00
-
0.55
45.21%
0.39
29.65%
0.57
46.09%
0.60
6.33%
0.72
19.84%
0.63
12.62%
2.74
334.75%
2.44
10.99%
2.09
14.20%
receivables turnover
4.66
-
5.20
11.67%
5.39
3.77%
5.19
3.83%
5.03
3.12%
4.35
13.41%
4.52
3.74%
4.15
8.10%
4.94
19.16%
4.54
8.11%
research and ddevelopement to revenue
0.65
-
0.61
4.99%
0.71
16.08%
0.59
16.92%
0.46
21.55%
0.47
0.44%
0.42
10.14%
0.34
19.54%
0.34
0.88%
0.31
9.00%
0.31
0.40%
return on tangible assets
-0.09
-
-0.06
32.29%
-0.06
2.63%
-0.19
219.25%
-0.03
84.49%
-0.02
30.85%
-0.01
71.39%
0.16
2,877.85%
-0.01
107.21%
0.02
304.96%
revenue per share
3.98
-
5.13
28.89%
5.56
8.36%
6.73
21.00%
7.53
11.93%
8.42
11.83%
9.52
13.01%
10.29
8.11%
10.10
1.87%
11.31
12.05%
12.63
11.61%
roe
-0.13
-
-0.09
33.32%
-0.07
18.39%
-0.23
218.37%
-0.04
81.71%
-0.03
37.57%
-0.01
70.64%
0.21
2,839.42%
-0.02
107.17%
0.03
304.96%
roic
-0.08
-
-0.05
41.60%
-0.04
11.99%
-0.18
340.14%
-0.01
93.18%
-0.02
46.13%
-0.01
54.95%
0.38
4,836.50%
-0.01
102.53%
0.01
200.43%
sales general and administrative to revenue
0.43
-
0.40
6.24%
0.45
12.36%
0.43
5.60%
0.42
1.11%
0.41
3.96%
0.18
-
0.19
6.80%
0.19
0.37%
shareholders equity per share
9.73
-
10.44
7.24%
15.00
43.71%
16.67
11.08%
16.10
3.38%
16.76
4.10%
17.44
4.04%
22.71
30.22%
23.36
2.85%
24.85
6.38%
stock based compensation to revenue
0.12
-
0.12
2.64%
0.13
6.68%
0.12
3.81%
0.11
11.43%
0.10
6.53%
0.09
5.99%
0.10
8.69%
0.11
4.78%
0.09
12.34%
0.09
8.60%
tangible asset value
1.12B
-
1.32B
17.21%
1.52B
15.39%
2.02B
32.61%
2.09B
3.90%
2.28B
8.83%
2.47B
8.32%
3.49B
41.47%
3.69B
5.54%
4.07B
10.38%
tangible book value per share
8.16
-
9.00
10.33%
9.50
5.53%
12.14
27.85%
12.01
1.13%
12.87
7.21%
13.79
7.13%
19.32
40.09%
20.16
4.35%
21.96
8.94%
working capital
954.15M
-
1.19B
24.71%
644.18M
45.86%
982.48M
52.52%
1.39B
41.54%
1.53B
10.24%
1.01B
34.14%
1.85B
83.20%
1.73B
6.22%
2.16B
24.68%

All numbers in USD (except ratios and percentages)